CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
Thomas Stefan Worst(Heidelberg University), Philipp Erben(Heidelberg University), Arndt Hartmann(Universitätsklinikum Erlangen), Johannes Breyer(University of Regensburg), Christian Bolenz(Heidelberg University), Ralph M. Wirtz(Siemens Healthcare (Germany)), Simone Bertz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Markus Eckstein(Friedrich-Alexander-Universität Erlangen-Nürnberg), Cleo‐Aron Weis(Heidelberg University), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Wolfgang Otto(University of Regensburg)
Cited by 62
Related Papers
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study
|PLoS Medicine|2019|1.1k
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML)
|Leukemia|2012|417
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411